MedTrace Logo

Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction

NCT01073514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-12-22

No results posted yet for this study

Summary

To investigate bile culture and susceptibility test in patients with malignant biliary obstruction (MBO) or relation between bile, portal vein or vein culture and biliary infection. Also to get the information of bile metabonomics to find potential tumor marker .Culture of the organism is recognized as the "gold standard" for diagnosis of infection. Our research may be one of the first research on culture and susceptibility test in patients with MBO. The results of the trial research will be benefit to experiential therapy of MBO with biliary infection and diagnosis of MBO.

Conditions

  • Malignant Biliary Obstruction

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • YU HAI PENG, MD · Tianjin Medical University Cancer Institute and Hospital

  • GUO ZHI, Professor · Tianjin Medical University Cancer Institute and Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2016-11-30
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073514 on ClinicalTrials.gov